Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
Estefânia Gastaldello Moreira, Karine Maria Boll, Dalmo Guilherme Correia, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 11, pp. 1004-1020
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Role of oxidative stress in depression
Shvetank Bhatt, Anantha Naik Nagappa, Chandragouda R. Patil
Drug Discovery Today (2020) Vol. 25, Iss. 7, pp. 1270-1276
Closed Access | Times Cited: 540
Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation
Giulia Di Benedetto, Chiara Burgaletto, Carlo Maria Bellanca, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2728-2728
Open Access | Times Cited: 84
Towards a major methodological shift in depression research by assessing continuous scores of recurrence of illness, lifetime and current suicidal behaviors and phenome features
Michaël Maes, Bo Zhou, Ketsupar Jirakran, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 728-740
Open Access | Times Cited: 18
Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach
Michaël Maes, Juliana Brum Moraes, Kamila Landucci Bonifácio, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 3, pp. 509-521
Closed Access | Times Cited: 83
Microglia-Astrocyte Communication in Alzheimer’s Disease
Yingying Wu, Ulrich Eisel
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 3, pp. 785-803
Open Access | Times Cited: 36
Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis
Abbas F. Almulla, Yanin Thipakorn, Ali Abbas Abo Algon, et al.
Brain Behavior and Immunity (2023) Vol. 113, pp. 374-388
Open Access | Times Cited: 34
Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4578-4597
Closed Access | Times Cited: 58
Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity
Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 5, pp. 2333-2345
Closed Access | Times Cited: 50
Oxidative Stress Markers and Antioxidant Enzymes in Children and Adolescents with Depressive Disorder and Impact of Omega-3 Fatty Acids in Randomised Clinical Trial
Barbora Katrenčíková, Magdaléna Vaváková, Zuzana Paduchová, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1256-1256
Open Access | Times Cited: 43
Multiple chemical sensitivity: It's time to catch up to the science
John Molot, Margaret Sears, Hymie Anisman
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105227-105227
Open Access | Times Cited: 15
Disentangling the effects of PTSD from Gulf War Illness in male veterans via a systems-wide analysis of immune cell, cytokine, and symptom measures
Esha Sultana, Nandan Shastry, Rishabh Kasarla, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 5
The Antioxidant Enzyme PON1: A Potential Prognostic Predictor of Acute Ischemic Stroke
Yuzhen Xu, Kai Wang, Qian Wang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 32
Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis
Xue Xin Goh, Pek Yee Tang, Shiau Foon Tee
Psychiatry Research (2022) Vol. 309, pp. 114429-114429
Closed Access | Times Cited: 19
Key factors underpinning neuroimmune-metabolic-oxidative (NIMETOX) major depression in outpatients: paraoxonase 1 activity, reverse cholesterol transport, increased atherogenicity, protein oxidation, and differently expressed cytokine networks.
Michaël Maes, Ketsupar Jirakran, Laura de Oliveira Semeão, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A pathway phenotype linking metabolic, immune, oxidative, and opioid pathways with comorbid depression, atherosclerosis, and unstable angina
Rana Fadhil Mousa, Hasan Najah Smesam, Hasan Abbas Qazmooz, et al.
CNS Spectrums (2021) Vol. 27, Iss. 6, pp. 676-690
Closed Access | Times Cited: 25
Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways
Michaël Maes, Aristo Vojdani, M. Geffard, et al.
BioMolecular Concepts (2019) Vol. 10, Iss. 1, pp. 209-225
Open Access | Times Cited: 26
The role of immune and oxidative pathways in menstrual cycle associated depressive, physio-somatic, breast and anxiety symptoms: Modulation by sex hormones
Chutima Roomruangwong, Andressa Keiko Matsumoto, Ana Paula Michelin, et al.
Journal of Psychosomatic Research (2020) Vol. 135, pp. 110158-110158
Closed Access | Times Cited: 24
A Novel Pathway Phenotype of Temporal Lobe Epilepsy and Comorbid Psychiatric Disorders: Results of Precision Nomothetic Medicine
Michaël Maes, Décio Sabbatini Barbosa, Abbas F. Almulla, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 803-803
Open Access | Times Cited: 16
Major depression, suicidal behaviors and neuroticism are pro-atherogenic states driven by lowered reverse cholesterol transport
Ketsupar Jirakran, Asara Vasupanrajit, Chavit Tunvirachaisakul, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Towards a major methodological shift in depression research by assessing continuous scores of recurrence of illness, lifetime and current suicidal behaviors and phenome features: focus on atherogenicity and adverse childhood experiences
Michael Maes, Ketsupar Jirakran, Asara Vasupanrajit, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation
Andressa Keiko Matsumoto, Michaël Maes, Thitiporn Supasitthumrong, et al.
CNS Spectrums (2020) Vol. 26, Iss. 4, pp. 406-415
Closed Access | Times Cited: 19
Menstruation distress is strongly associated with hormone-immune-metabolic biomarkers
Chutima Roomruangwong, Sunee Sirivichayakul, Andressa Keiko Matsumoto, et al.
Journal of Psychosomatic Research (2021) Vol. 142, pp. 110355-110355
Closed Access | Times Cited: 15
Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders
Katarzyna Bliźniewska-Kowalska, Piotr Gałecki, Kuan-Pin Su, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3321-3321
Open Access | Times Cited: 10
Benefits and Meaning of Lipids Profile in Relation to Oxidative Balance and Brain Morphology in Schizophrenia
Natalia Śmierciak, Wirginia Krzyściak, Marta Szwajca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11375-11375
Open Access | Times Cited: 6
Reduced paraoxonase 1 activities may explain the comorbidities between temporal lobe epilepsy and depression, anxiety and psychosis
Ana Paula Michelin, Michaël Maes, Thitiporn Supasitthumrong, et al.
World Journal of Psychiatry (2022) Vol. 12, Iss. 2, pp. 308-322
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top